The global IVD contract manufacturing market size was USD 17.19 billion in 2023, calculated at USD 19.17 billion in 2024 and is projected to surpass around USD 56.94 billion by 2034, expanding at a CAGR of 11.5% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: IVD Contract Manufacturing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. IVD Contract Manufacturing Market, by Device Type, 2024-2034
8.1.1 IVD Equipment
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. IVD Consumables
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. IVD Contract Manufacturing Market, by Technology, 2024-2034
9.1.1. Immunoassay
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Clinical Chemistry
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Molecular Diagnostics
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Microbiology
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Hematology
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Coagulation & Hemostasis
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2021-2034)
10.1. IVD Contract Manufacturing Market, by Service Type, 2024-2034
10.1.1. Manufacturing Services
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Assay Development Services
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Other Services
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.1.2. Market Revenue and Forecast, by Technology (2021-2034)
11.1.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.2.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.3.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.5.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Technology (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Service Type (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Device Type (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Service Type (2021-2034)
12.1. Thermo Fisher Scientific Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Siemens Healthineers AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Danaher Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Roche Diagnostics
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Ortho Clinical Diagnostics
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Abbott Laboratories
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bio-Rad Laboratories, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sysmex Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Quidel Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. BioMérieux SA
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client